Literature DB >> 11185708

Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection.

M Niedergethmann1, R Hildenbrand, G Wolf, C S Verbeke, A Richter, S Post.   

Abstract

BACKGROUND: Curative resection of pancreatic adenocarcinoma is the only clinical parameter related to a favorable prognosis while other clinicopathological parameters fail. To evaluate whether angiogenesis, vascular endothelial growth factor (VEGF) or certain tumor proteases, e.g., cathepsin B (CTSB) and L (CTSL), are factors of prognostic relevance, we investigated their expression in patients with long- and short-term survival after curative resection (RO) because of pancreatic adenocarcinoma.
METHODS: Twenty-nine tissue samples from patients with adenocarcinoma of the pancreas were examined. The patients were selected in a long-term survival group with a survival > or = 24 mo (n = 18) and a shortterm survival group of patients, who died within 8 mo after surgery because of their malignancy (n = 11). The microvessel quantification was performed immunohistochemically using a monoclonal anti-CD34 antibody. VEGF, CTSB, and CTSL expressions was studied using polyclonal antibodies (PAbs).
RESULTS: The median microvessel density (MVD) was 75 (range 39-182). MVD correlated significantly with the survival time after surgery (p = 0.0132) but not with clinicopathological parameters. In cancer cells, VEGF was positive in 82.8% and showed significant correlation with the MVD (p = 0.0002) and survival time (p = 0.0395). Positive immunoreactivity could be obtained for 96.5% for CTSB and 84.2% for CTSL. Expression of both proteases correlated significantly with the survival time after surgery (CTSB p = 0.0002, CTSL p = 0.0001). Furthermore, CTSB expression correlated with invasion of the perineural space. Thus, a short postoperative survival correlated with a high MVD, and highly expressed VEGF, CTSB, and CTSL. No significant correlation between MVD, VEGF, as well as CTSL and clinicopathological parameters was found. For routinely assessed markers (e.g., TNM-stage, UICC-stage, and so on) no significant correlation with survival time was found in this small group of patients.
CONCLUSION: These findings indicate that the MVD, VEGF, CTSB, and CTSL are prognostic factors after curative resection, whereas other parameters (TNM, UICC, and so on) failed to show prognostic relevance in our group of patients. Furthermore, the correlation between MVD and VEGF underlines the importance of this growth factor for angiogenesis and tumor growth. The correlation between CTSB and perineural invasion demonstrates the involvement of cathepsins in local tumor invasion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11185708     DOI: 10.1385/IJGC:28:1:31

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  34 in total

Review 1.  Pancreatic carcinoma.

Authors:  A L Warshaw; C Fernández-del Castillo
Journal:  N Engl J Med       Date:  1992-02-13       Impact factor: 91.245

2.  Characterization of a cathepsin L-like enzyme secreted from human pancreatic cancer cell line HPC-YP.

Authors:  N Yamaguchi; S M Chung; O Shiroeda; K Koyama; J Imanishi
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

3.  Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality.

Authors:  M Trede; G Schwall; H D Saeger
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

4.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

Review 5.  Molecular advances in pancreatic cancer.

Authors:  N R Lemoine
Journal:  Digestion       Date:  1997       Impact factor: 3.216

6.  Immunocytochemical localization of cathepsins B and H in human pancreatic endocrine cells and insulinoma cells.

Authors:  B Im; E Kominami; D Grube; Y Uchiyama
Journal:  Histochemistry       Date:  1989

Review 7.  The vascular endothelial growth factor family of polypeptides.

Authors:  N Ferrara; K A Houck; L B Jakeman; J Winer; D W Leung
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

Review 8.  Prognostic factors in ductal pancreatic cancer.

Authors:  C J Yeo; J L Cameron
Journal:  Langenbecks Arch Surg       Date:  1998-04       Impact factor: 3.445

9.  Pancreatic trypsinogen and cathepsin B in human pancreatic carcinomas and associated metastatic lesions.

Authors:  T Ohta; T Terada; T Nagakawa; H Tajima; H Itoh; L Fonseca; I Miyazaki
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

10.  Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

Authors:  M Detmar; L F Brown; K P Claffey; K T Yeo; O Kocher; R W Jackman; B Berse; H F Dvorak
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  20 in total

1.  Impact of microvessel density on lymph node metastasis and survival after curative resection of pancreatic cancer.

Authors:  Christoph Benckert; Armin Thelen; Thorsten Cramer; Wilko Weichert; Gereon Gaebelein; Reinhard Gessner; Sven Jonas
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Differentially expressed genes between solitary large hepatocellular carcinoma and nodular hepatocellular carcinoma.

Authors:  Lian-Yue Yang; Wei Wang; Ji-Xiang Peng; Jie-Quan Yang; Gen-Wen Huang
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

3.  Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer.

Authors:  Alok A Khorana; Ying Chuan Hu; Charlotte K Ryan; Richard A Komorowski; Galen Hostetter; Steven A Ahrendt
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

4.  Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.

Authors:  Hubert G Hotz; Parkash S Gill; Rizwan Masood; Birgit Hotz; Heinz J Buhr; Thomas Foitzik; O Joe Hines; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2002 Mar-Apr       Impact factor: 3.452

5.  Expression of hypoxia-inducible factor 1alpha and cathepsin D in pituitary adenomas.

Authors:  Daizo Yoshida; Kyongsong Kim; Michio Yamazaki; Akira Teramoto
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 6.  Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis.

Authors:  Yoko Matsuda; Masahito Hagio; Toshiyuki Ishiwata
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 7.  Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; John Wong
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

8.  A functional and regulatory network associated with PIP expression in human breast cancer.

Authors:  Marie-Anne Debily; Sandrine El Marhomy; Virginie Boulanger; Eric Eveno; Régine Mariage-Samson; Alessandra Camarca; Charles Auffray; Dominique Piatier-Tonneau; Sandrine Imbeaud
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

9.  The metastatic potential of human pancreatic cell lines in the liver of nude mice correlates well with cathepsin B activity.

Authors:  George N Tzanakakis; Andrew N Margioris; Aristidis M Tsatsakis; Michael P Vezeridis
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 10.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.